-
Font Size:
-
Print
- TweetThis
Shares of Rite Aid (RAD) plunged more than 30% after the drugstore chain reported a larger third-quarter loss than analysts' estimated and lowered its full-year outlook. For the quarter, the company's net loss was $84.8 million ($-0.12/share) compared to a net income of $1.1 million ($-0.01/share) last year. Revenue climbed 51% to $6.52 billion, mostly from the acquisition of Brooks Eckerd.
Forecasters were anticipating a net loss of $0.07/share on $6.64 billion in revenue. The company pointed to weak flu medicine sales and less demand for digital-film processing and snacks. "They mentioned a weakening consumer for a company that people thought was somewhat recession resistant," said Carla Casella, an analyst at JPMorgan Chase. "It's a little scary when they start talking about a weakening consumer. People are going to lose patience."
Rite Aid also lowered its expected fiscal year sales to $24.3-$24.6 billion from $24.5-$25.1 billion. It sees yearly earnings falling to a loss of $0.27-$0.31/share from the loss of $0.15-$0.27/share it previously anticipated. "As we look forward to the remainder of our fiscal year, like the rest of the industry, we continue to be challenged by a weaker cough, cold and flu season than last year" and "a more cautious consumer," said CEO Mary Sammons.
Rite Aid closed down 31.7% to $2.80.
Seeking Alpha's news briefs are combined into a pre-market summary called Wall Street Breakfast. Get Wall Street Breakfast by email -- it's free and takes only seconds to sign up.
Related Articles
|



























This article has 1 comment: